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Background: Multiple sclerosis (MS) is a complex autoimmune disease mediated by an immune response to
central nervous system antigens. Modern immunomodulatory therapies, however, do not ameliorate many of the
symptoms, such as pain and depression. Patients thus seek alternative treatments, such as acupuncture, although
the benefits of such treatments have not been objectively evaluated. The present study was thus designed to
evaluate the effect of the use of acupuncture in the alleviation of the symptoms of patients with MS.
Methods: Thirty-one patients with Relapsing-Remitting Multiple Sclerosis undergoing treatment with
immunomodulators were randomly distributed into sex-stratified experimental and placebo groups in a patient-
and evaluator-blind design; they received either true or sham electroacupuncture during regular visits to the doctor
in the university hospital outpatient clinic. Standardized questionnaires were used to evaluate the effect of
electroacupuncture on the quality of life of these patients. Initial and follow-up assessment included the evaluation
of clinical status (Expanded Disability Status Scale), pain (Visual Analogue Scale) and quality of life (Functional
Assessment of multiple Sclerosis) to ascertain the impact of electroacupuncture on the quality of life of these
patients.
Results: Electroacupuncture improved various aspects of quality of life, including a reduction in pain and
depression. The self-report scales were more sensitive to improvement than was the more objective clinical
measure.
Conclusion: This paper provides evidence that electroacupuncture can significantly improve the quality of life of
such patients. The results suggest that the routine use of a self-report scale evaluating quality of life should be
included in regular clinical evaluations in order to detect changes more rapidly.
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167 Patients assessed for Eligibility
136 Excluded:
120 Patients who lived too
far (over 100Km) from the
city of Campinas.
10 Patients who had
previously received
acupuncture.





16 Assigned to True
Electroacupuncture (TEA)
group.
None lost to follow-up or
excluded from analysis
15 Assigned to Sham
Electroacupuncture (SEA)
group.
None lost to follow-up or
excluded from analysis
Figure 1 Flow diagram outlining participant selection.
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Multiple sclerosis is a complex autoimmune disease
mediated by the individual immune response against
central nervous system (CNS) antigens. Its causes are
unknown, although, both genetic and environmental
components play important roles and interact to produce
susceptibility to the disease and influence its course [1].
For the relapsing-remitting type of multiple sclerosis
(RRMS), various immunomodulatory therapies have been
developed, with an effectiveness of some 35%, and these
have had a significant impact on the natural history
of the disease [2-4]. However, although these agents do
reduce the relapse rate, they do not ameliorate many of
the symptoms and lead to undesirable side effects [5].
Patients may still complain of diverse symptoms, such as
difficulty in walking, incontinence, impaired sexual func-
tion, and pain, all of which lead to a poor quality of life
(QOL) [6], and many seek alternative treatments such as
acupuncture. Acupuncture, which is an important com-
ponent of Traditional Chinese Medicine (TCM), involves
the insertion of metallic needles into specific points,
stimulating them either manually or electrically (eletroa-
cupuncture) [7]. Its increase in popularity during recent
years has not gone unnoticed by the medical community
with clinical trials using acupuncture for the alleviation
of pain and stroke rehabilitation [8-12]. Nevertheless,
few reports address the benefits of this treatment on the
quality of the life of RRMS patients [13]. Our aim was
thus to study the effect of electroacupuncture on the
QOL of patients with RRMS undergoing treatment with
immunomodulators, using standardized questionnaires
to evaluate these effects.
Method
Subjects
The study was carried out in the MS outpatient clinic
of the University of Campinas Hospital (UNICAMP) in
Campinas in the State of São Paulo in Brazil between
2008 and 2010. A total of 167 patients with a confirmed
diagnosis of RRMS according to the revised 2010
McDonald criteria and under treatment with immunomo-
dulatory drugs (interferon-beta and glatiramer acetate)
were identified [14,15]. The sample selected consisted of
all 31 living close enough to appear for weekly appoint-
ments and who had not previously received acupuncture
treatment (Figure 1); these subjects were distributed into
true acupuncture and placebo (sham acupuncture)
groups. All patients provided informed consent and
agreed to receive one of two interventions, either true
electroacupuncture (TEA) or sham electroacupuncture
(SEA). They were informed that it was possible that this
procedure might or might not have any effect on their
condition. The study was approved by the University of
Campinas Committee for Ethical Research CAAE -0775.0.146.000-08 and The Brazilian Clinical Trials
Registry (RBR-58yq52, http://ecgovbr2.bvsalud.org/).
Randomization and blinding
Simple randomization to allocate patients to equal parallel
groups receiving TEA or SEA treatments was based on a
table of random numbers, with the groups stratified by
sex. The study involved a patient- and evaluator-blind
design. Only the practitioner, an experienced acupunc-
turist with more than ten years of experience and accre-
dited by the Brazilian National Council for Biomedicine
in the area of acupuncture, was aware of the intervention
to be used. Treatment was applied following individual
schedules so that none of the patients had any contact
with the others in the study. Moreover, all patients
agreed not to have contact with other participants and to
avoid talking about their treatment. Initial assessment
included the application of three previously validated
instruments to evaluate 1) clinical status (Expanded
Disability Status Scale), 2) pain (Visual Analogue Scale)
and 3) quality of life (Functional Assessment of multiple
Sclerosis).
Intervention
All patients were receiving conventional treatment for
RRMS, which involves a self-administered daily injection
of interferon beta 1-a or interferon beta 1-b, and this
treatment was continued throughout the present study




# (years*) SD F/M Years
with MS*
SD
SEA1 15 40.1 (9.1) 13/2 9.3 (7.0)
TEA2 16 36.0 (11.5) 14/2 7.6 (6.0)
*Mean, 1sham electroacupuncture (SEA), 2true electroacupuncture (TEA).
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of the two groups. The protocol consisted of 30 minutes
of electroacupuncture (either true or sham) once a week
for six consecutive months.
A single treatment protocol was developed for all
patients on the basis of acupuncture points reported to
stimulate the immune system [16-21]. Disposable stain-
less steel needles (diameter 0.20 mm x length 30 mm;
Dongbang, Republic of Korea) were used. For the experi-
mental group, the needles were inserted bilaterally at the
points Zusanli (ST36), Sanyinjiao (SP6), Hegu (LI4) and
Quchi (LI11), with a ninth needle inserted at Yintang
(EX-HN3); the location of the points, angle of insertion
and depth of insertion were based on the references in a
classic text of Chinese medicine [22]. The “de qi” (mani-
festation of sensation in response to the presences of the
needle) was sought for each point. In the SEA group,
needle insertion was more superficial (less than 0.2 cm)
and one centimeter to the side of the critical points used
for the TEA group, with care taken to avoid areas corre-
sponding to any of the 14 meridians of TCM. After the
needles were inserted, they were connected to the term-
inals of a six-channel KWD 808 serial impulse electrosti-
mulator (Changzhou, China) set to run on alternating
current and produce an electrical stimulus of 4 Hz in dis-
continuous waves, with a pulse width of 0.5 ms. The
stimulation was applied to each of the needles (except
for that in Yintang) for the TEA group, while for the
SEA group, no actual electrical stimulation was given.
Outcome measures
Clinical status was assessed prior to the treatment, as
well as after six months, using the Expanded Disability
Status Scale (EDSS), which is an instrument used to
evaluate neurological impairment on a scale of 0 (normal
capacity) to 10 (death) [23]. Quality of life was also
assessed prior to the initiation of treatment, as well as
after three and six months; it was measured by the Func-
tional Assessment of Multiple Sclerosis (FAMS) instru-
ment, validated for Portuguese [24,25]. Briefly, this is a
disease-specific 44-item self-report questionnaire investi-
gating patient perception of the quality of their lives,
using a 5-point Likert-type scale ranging from “not at all”
to “very much”, which yields a score between 0 (for not
at all) and 4 (for very much) for each of the items. The
six sub-scales assess mobility, symptoms, emotional well
being/depression, general contentment, thinking/fatigue,
and family/social well being; moreover, patient observa-
tions of perceived changes in their lives with treatment
were also noted. Pain was evaluated using the 10-point
Visual Analogue Scale (VAS), applied just before each
application of the FAMS. Miscellaneous improvements
were occasionally mentioned by patients, and these were
also noted.Statistical analysis
Data were analyzed using SAS System for Windows
software, version 9.2 (SAS Institute, Cary, NC, USA),
with a Fisher0s exact test used to determine differences
between proportions. The Mann–Whitney test was used
for between-group comparisons of the parameters evalu-
ated. An analysis of variance (ANOVA) test with repeated
measures was used for between-group comparison of the
ranked parameters, as well as to ascertain differences due
to length of treatment. The statistical tests were two-
tailed, with level of significance set at 5%.Results
Figure 1 provides a flow diagram of the selection and
treatment of the two groups, with sixteen in the TEA
group and fifteen in the SEA. The groups were similar
with respect to age, gender, and duration of the disease
(Table 1).
Clinical status
The clinical evaluations based on the EDSS were similar
for the two groups at the beginning of the study (initial
means of 3.0 and 2.3 for the SEA and TEA groups,
respectively (p=0.3). After 6 months of treatment, how-
ever, the group receiving the SEA had shown somewhat
more deterioration, although the difference between the
two groups only approached significance (3.3 vs 2.2;
p = 0.055). Nevertheless, when including the effect of
duration of treatment using the ANOVA test, there was a
significant interaction effect, with the patients receiving
the sham treatment receiving higher (worse) scores than
those receiving true electroacupuncture (Pinteraction effect =
0.0338; Figure 2).
Quality of life
Although initial QOL scores for all subscales were
similar for the two groups (with p-values ranging from
0.0985 to 0.5333), after treatment there was a signifi-
cant difference between the groups (p-values of 0.0026
and <0.0001 after three and six months, respectively).
Only the thinking/fatigue subscale showed no significant
difference between groups after treatment (p = 0.073
for both time periods). These improvements are shown
in Figures 2, 3, 4 and 5. The SEA group did show a
Figure 2 Assessment of neurological involvement of patients,
including mobility, based on results of Expanded Disability
Status Scale (EDSS) administered before treatment and after
six months of weekly electroacupuncture (or sham
electroacupuncture) sessions and of self-assessed mobility as
revealed by the mobility subscale of the Functional Assessment
of Multiple Sclerosis questionnaire (FAMS).
Figure 3 Overall Results of Functional Assessment of Multiple
Sclerosis questionnaire (FAMS) administered prior to treatment,
as well as after three and six months of weekly
electroacupuncture (or sham electroacupuncture) sessions.
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after three months of treatment (p < 0.01), but this did
not persist to the end of treatment (p > 0.10).Pain
The presence of pain, evaluated by the VAS, was similar
for the two groups prior to the initiation of the electroa-
cupuncture treatment (p = 0.42), but true electroacu-
puncture significantly reduced the pain felt by patients
with RRMS, an effect observed after both three and six
months (p = 0.014 and 0.0001, respectively). For the group
receiving the sham treatment, there was an improvement
after three months, (p = 0.028), but the ameliorationwas not sustained to the end of the treatment (p = 0.1)
(Figure 6).Other effects
In addition to the actual results of the study, the partici-
pants in the TEA group reported various improvements,
such as better sleep and appetite and reduced incontin-
ence and constipation; three participants in this group
also reported the disappearance of leg spasms during
treatment. Although these effects were not systematically
measured, since they were not included in the initial study
design, these reports suggest that the positive effects of
acupuncture for patients with multiple sclerosis may go
beyond the specific aspects of QOL measured. No adverse
effects were reported by the patients in either group.Discussion
As this study of electroacupuncture on RRMS patients
has shown, the use of the technique does indeed improve
QOL, which includes the general contentment of these
patients, as well as family and social well-being. One of
the most incapacitating aspects of the disease is the
gradual loss of mobility with the advance of the dis-
ease [6]. This study included two measures of this mo-
bility, the EDSS, assessed by a neurologist, and the
self-report of mobility subscale of the FAMS. Although
the results of the EDSS showed a slightly reduced ad-
vance in the results of neurological damage caused by
the disease for the patients receiving TEA, the difference
between the two groups only approached significance.
The results of the mobility subscale of the FAMS,
Figure 5 Assessment of Quality of Life based on Family/Social
well-being, and General Contentment subscales of Functional
Assessment of Multiple Sclerosis questionnaire (FAMS),
administered prior to treatment, as well as after three and six
months of weekly electroacupuncture (or sham
electroacupuncture) sessions.
Figure 4 Assessment of Quality of Life based on Symptoms
and Emotional well-being (depression) subscales of the
Functional Assessment of Multiple Sclerosis questionnaire
(FAMS), administered prior to treatment, as well as after three
and six months of weekly electroacupuncture (or sham
electroacupuncture) sessions.
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bility in the eyes of the patients who had received the
TEA. This discrepancy in values is not surprising, since
the FAMS score is considerably more subjective, and pa-
tient self-impressions are generally not assessed by the
EDSS. Furthermore, the latter measures overall perform-
ance, and changes on this level take some time to appear.
The degenerative nature of the disease means that
actual performance will constantly worsen, and the re-
duction in mobility of the patients submitted to sham
electroacupuncture was noticeable, even in the short
six-month period evaluated. The degeneration of those
receiving TEA, however, was held in abeyance.On the other hand, the patient-evaluated QOL is more
sensitive to short-term alterations, which would make it
possible for the doctor to observe relevant changes in
the state of the patient and modify treatment to improve
the situation. It is, however, the EDSS which is generally
adopted for the evaluation of the mobility of the patient
with RRMS. Since the results of this test ignore the quality
of the life of the patient, the addition of a test such as
FAMS, which does measure it, could be of great benefit
to the well-being of a patient.
The life of patients with RRMS tends to be a solitary
one for various reasons, not the least of which is the fre-
quent presence of pain, which affect some 29-86% of all
Figure 6 Assessment of pain based on results of Visual
Analogue Scale (VAS) administered prior to treatment, as well
as after three and six months of weekly electroacupuncture
(or sham electroacupuncture) sessions.
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that patients with chronic pain suffer from reduced social
adjustment and an increase in psychiatric morbidity
[27-30]. Although pain is rarely considered in the clinical
evaluation of RRMS, it does seem important to deal
with such a potentially incapacitating aspect of the dis-
ease, especially since the results of this study show
that it can be efficiently dealt with using electroacupunc-
ture. These results are in agreement with those of previ-
ous studies which have demonstrated the analgesic effect
of acupuncture, which is known to ameliorate the de-
regulation of sensory information in the processing of
pain [31-36].
The stigmatization of those with RRMS also contri-
butes to the isolation of these patients; this effect is
enhanced by many of the symptoms of RRMS, especially
depression, which has a strong negative impact on the
life of patients [37]. Depression occurs in as many as 60%
of patients with multiple sclerosis, although it is inde-
pendent of the disability inherent in the clinical course of
the disease [38]. Not only does depression lead to the
isolation of patients from their friends and families, but,
when chronic, can even lead to attempts at suicide [6,39].
It can, however, be largely controlled. If the depressive
state of a patient can be identified, some of the damage
resulting from it can be ameliorated, if not prevented.
This study, for example, has shown that electroacu-
puncture can improve the emotional well being of RRMS
patients, with results visible after only three months,
although this is not normally assessed in the routine
evaluation of RRMS patients.Conclusions
A reasonable quality of life is important in stimulating
the desire of an RRMS patient to live as full a life as
possible. QOL, however, is not a direct reflection of the
neurological development of the disease. This paper
provides evidence that electroacupuncture can signifi-
cantly improve various domains of the QOL of MS
patients, especially pain. In normal clinical evaluations
of the disease, however, emphasis is limited to physical
incapacity, and QOL as such is ignored. The regular
use of self-evaluation scales such as the FAMS should
help identify problems which could be relieved, as
well as helping evaluate the efficacy of traditional treat-
ments, since such self-evaluations often reveal more
rapid responses to treatment than do the more objective
evaluations of trained professionals.
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